Abstract
Sensitive/less‐sensitive (S/LS) serum‐based serologic methods have been developed to measure human immunodeficiency virus (HIV) incidence by distinguishing recent from established infections. Such methods require venipuncture. The goal of this study was to develop an alternative to serum‐based S/LS testing using oral fluid (OF) as the testing medium. Serum/OF pairs were collected from 342 patients attending 15 Adolescent Trials Network (ATN) clinical sites. The sera were tested with the use of the dilutional Vironostika (DV; Biomerieux, Durham, NC) S/LS assay (DVSOD=1.0) as the reference against which an OF LS assay was calibrated using 40 of the OF pairs. Receiver operating characteristic (ROC) curve analyses pinpointed the OF LS test parameters that maximized concordance with the serum‐based DV. Validation of the calibrated OF LS included testing of the remaining 302 serum/OF pairs. During calibration the maximum concordance with the DV was 95.2% and 89.5% for 21 recent and 19 established samples, respectively, at a 1:50 OF sample dilution and an optical density (OD) cutoff of 0.280. When applied to the validation sample set (N=302), the concordance was 73.6% for the recent samples and 89.6% for the established samples. The OF LS assay showed a good concordance with the serum‐based reference S/LS assay. It presents an alternative to invasive specimen collection, and has the potential for increasing test compliance in young subjects. However, because of the uncertainty of the performance characteristics of the serum‐based S/LS assay with which it was compared, further validation of the OF LS using seroconversion sample pairs is needed. J. Clin. Lab. Anal. 21:40–45, 2007. © 2007 Wiley‐Liss, Inc.
Keywords: HIV, saliva, incidence, S/LS, adolescents
REFERENCES
- 1. Constantine NT, Zink H. HIV testing technologies after two decades of evolution. Indian J Med Res 2005;121:519–538. [PubMed] [Google Scholar]
- 2. Dobbs T, Parekh BS. Detecting recent human immunodeficiency virus type 1 infection: why and how? MLO Med Lab Obs 2003;35:12–14, 16, 19–20 passim; quiz 24–25. [PubMed] [Google Scholar]
- 3. Rutherford GW, Schwarcz SK, McFarland W. Surveillance for incident HIV infection: new technology and new opportunities. J Acquir Immune Defic Syndr 2000;25(Suppl 2):S115–S119. [DOI] [PubMed] [Google Scholar]
- 4. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV‐1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280:42–48. [DOI] [PubMed] [Google Scholar]
- 5. UNAIDS Reference Group on Estimates , Modeling and Projections statement on the use of the BED‐assay for the estimation of HIV‐1 incidence for surveillance or epidemic monitoring 2005. <www.epidem.org/Publications/BED%20statement.pdf> [PubMed]
- 6. Constantine NT, Sill AM, Cleghorn FR, et al. Improved classification of recent HIV‐1 infection by employing a two‐stage sensitive/less‐sensitive test strategy. J Acquir Immune Defic Syndr 2003;32:94–103. [DOI] [PubMed] [Google Scholar]
- 7. Constantine NT, Saville R, Dax EM. Retroviral testing and quality assurance: essentials for laboratory diagnosis. Ann Arbor: Malloy: 2005. Malloy Printers, ISBN: 0‐9785982‐0‐2;2005. [Google Scholar]
- 8. Peralta L, Constantine N, Griffin‐Deeds B, Martin L, Ghalib K. Evaluation of youth preferences for rapid and innovative human immunodeficiency virus antibody tests. Arch Pediatr Adolesc Med 2001;155:838–843. [DOI] [PubMed] [Google Scholar]
- 9. Rawal BD, Degula A, Lebedeva L, et al. Development of a new less‐sensitive enzyme immunoassay for detection of early HIV‐1 infection. J Acquir Immune Defic Syndr 2003;33:349–355. [DOI] [PubMed] [Google Scholar]
- 10. Kothe D, Byers RH, Caudill SP, et al. Performance characteristics of a new less sensitive HIV‐1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 2003;33:625–634. [DOI] [PubMed] [Google Scholar]
- 11. Begg CB. Statistical methods in medical diagnosis. CRC Crit Rev Med Inform 1986;1:1–22. [PubMed] [Google Scholar]